Directed differentiation of human pluripotent stem cells to blood-brain barrier endothelial cells
Open accessThe DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Abstract
We report a defined method for differentiating human pluripotent stem cells to brain endothelial cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“ROCK inhibitor is widely used during passaging of hiPSCs and, in some cases, during dhBMEC seeding, to alleviate cell stress [40, 41].”
From Role of iPSC-derived pericytes on barrier function of iPSC-derived brain microvascular endothelial cells in 2D and 3D (2019) · cites this paper as [41]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Other studies have shown mixed results regarding the effect of pericytes or other supporting cell types on TEER of dhBMEC monolayers [20, 33, 36, 41, 52–54].”
From Role of iPSC-derived pericytes on barrier function of iPSC-derived brain microvascular endothelial cells in 2D and 3D (2019) · cites this paper as [41]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Yamamizu, K., Iwasaki, M., Takakubo, H., Sakamoto, T., Ikuno, T., Miyoshi, M., Kondo, T., Nakao, Y., Nakagawa, M., Inoue, H., et al. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.01.023 · Cited by 49
RetractedEmbryonic Stem Cell Lines Derived from Human Blastocysts
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., & Jones, J. M. (1998) · Science · doi:10.1126/science.282.5391.1145 · Cited by 15,926
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Astrocyte-endothelial interactions at the blood-brain barrier
Abbott, N. J., Rönnbäck, L., & Hansson, E. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1824 · Cited by 5,595
Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling
Chambers, S. M., Fasano, C. A., Papapetrou, E. P., Tomishima, M., Sadelain, M., & Studer, L. (2009) · Nature Biotechnology · doi:10.1038/nbt.1529 · Cited by 3,620
The blood-brain barrier: Bottleneck in brain drug development
Pardridge, W. M. (2005) · NeuroRX · doi:10.1602/neurorx.2.1.3 · Cited by 2,798
Development, maintenance and disruption of the blood-brain barrier
Obermeier, B., Daneman, R., & Ransohoff, R. M. (2013) · Nature Medicine · doi:10.1038/nm.3407 · Cited by 2,452 · cited 1×
“The primary anatomical component of the BBB is provided by brain microvascular endothelial cells (BMECs) (1, 2) that work in concert with supporting cells, such as astrocytes, pericytes, and neurons, to form the neurovascular unit (1, 3, 4).”
BackgroundHuman induced pluripotent stem cells free of vector and transgene sequences
Yu, J., Hu, K., Smuga-Otto, K., Tian, S., Stewart, R., Slukvin, I. I., & Thomson, J. A. (2009) · Science · doi:10.1126/science.1172482 · Cited by 2,386
The blood–brain barrier: an overview
Ballabh, P., Braun, A., & Nedergaard, M. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.12.016 · Cited by 2,261
In vitro differentiation of transplantable neural precursors from human embryonic stem cells
Zhang, S.-C., Wernig, M., Duncan, I. D., Brüstle, O., & Thomson, J. A. (2001) · Nature Biotechnology · doi:10.1038/nbt1201-1129 · Cited by 1,912
Cited by
Modeling Alzheimer’s disease with iPSC-derived brain cells
Penney, J., Ralvenius, W. T., & Tsai, L.-H. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0468-3 · Cited by 471
Generation of vascularized brain organoids to study neurovascular interactions
Sun, X.-Y., Ju, X.-C., Li, Y., Zeng, P.-M., Wu, J., Zhou, Y.-Y., Shen, L.-B., Dong, J., Chen, Y.-J., & Luo, Z.-G. (2022) · eLife · doi:10.7554/elife.76707 · Cited by 378
Blanchard, J. W., Bula, M., Davila-Velderrain, J., Akay, L. A., Zhu, L., Frank, A., Victor, M. B., Bonner, J. M., Mathys, H., Lin, Y.-T., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0886-4 · Cited by 283
Modeling alpha-synuclein pathology in a human brain-chip to assess blood-brain barrier disruption
Pediaditakis, I., Kodella, K. R., Manatakis, D. V., Le, C. Y., Hinojosa, C. D., Tien-Street, W., Manolakos, E. S., Vekrellis, K., Hamilton, G. A., Ewart, L., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26066-5 · Cited by 237
In Vitro Models of the Blood-Brain Barrier
Neuhaus, W. (2020) · Handbook of Experimental Pharmacology · doi:10.1007/164_2020_370 · Cited by 236
Lu, T. M., Houghton, S., Magdeldin, T., Durán, J. G. B., Minotti, A. P., Snead, A., Sproul, A., Nguyen, D.-H. T., Xiang, J., Fine, H. A., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2016950118 · Cited by 224
“In summary, iBMECs can be obtained from PSCs using either the original method (1) or subsequently derived protocols (1, 2, 9, 18).”
InfluentialAdvances in Microfluidic Blood–Brain Barrier (BBB) Models
Oddo, A., Peng, B., Tong, Z., Wei, Y., Tong, W. Y., Thissen, H., & Voelcker, N. H. (2019) · Trends in Biotechnology · doi:10.1016/j.tibtech.2019.04.006 · Cited by 221
Neal, E. H., Marinelli, N. A., Shi, Y., McClatchey, P. M., Balotin, K. M., Gullett, D. R., Hagerla, K. A., Bowman, A. B., Ess, K. C., Wikswo, J. P., et al. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.05.008 · Cited by 208
Linville, R. M., DeStefano, J. G., Sklar, M. B., Xu, Z., Farrell, A. M., Bogorad, M. I., Chu, C., Walczak, P., Cheng, L., Mahairaki, V., et al. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2018.10.023 · Cited by 199
“Human induced pluripotent stem cells (iPSCs) differ entiated into BMECs (dhBMECs) display many of the hallmarks of the BBB in two-dimensional (2D) transwell assays including physiological TEER, permeability and efflux behavio r.(13-16) Interestingly, BBB phenotype is achieved without supporting cell types.”
Liu, C.-C., Zhao, J., Fu, Y., Inoue, Y., Ren, Y., Chen, Y., Doss, S. V., Shue, F., Jeevaratnam, S., Bastea, L., et al. (2022) · Nature Neuroscience · doi:10.1038/s41593-022-01127-0 · Cited by 168
Song, L., Yuan, X., Jones, Z., Griffin, K., Zhou, Y., Ma, T., & Li, Y. (2019) · Scientific Reports · doi:10.1038/s41598-019-42439-9 · Cited by 168
Dao, L., You, Z., Lu, L., Xu, T., Sarkar, A. K., Zhu, H., Liu, M., Calandrelli, R., Yoshida, G., Lin, P., et al. (2024) · Cell Stem Cell · doi:10.1016/j.stem.2024.04.019 · Cited by 159
Benchmarking in vitro tissue-engineered blood–brain barrier models
DeStefano, J. G., Jamieson, J. J., Linville, R. M., & Searson, P. C. (2018) · Fluids and Barriers of the CNS · doi:10.1186/s12987-018-0117-2 · Cited by 142
Bioengineering methods for vascularizing organoids
Nwokoye, P. N., & Abilez, O. J. (2024) · Cell Reports Methods · doi:10.1016/j.crmeth.2024.100779 · Cited by 187
Recent advances in human iPSC-derived models of the blood–brain barrier
Workman, M. J., & Svendsen, C. N. (2020) · Fluids and Barriers of the CNS · doi:10.1186/s12987-020-00191-7 · Cited by 141
Intrinsic blood–brain barrier dysfunction contributes to multiple sclerosis pathogenesis
Nishihara, H., Perriot, S., Gastfriend, B. D., Steinfort, M., Cibien, C., Soldati, S., Matsuo, K., Guimbal, S., Mathias, A., Palecek, S. P., et al. (2022) · Brain · doi:10.1093/brain/awac019 · Cited by 125
Self-citationLogan, S., Arzua, T., Canfield, S. G., Seminary, E. R., Sison, S. L., Ebert, A. D., & Bai, X. (2019) · Comprehensive physiology · doi:10.1002/cphy.c180025 · Cited by 153
Self-citationJamieson, J. J., Linville, R. M., Ding, Y. Y., Gerecht, S., & Searson, P. C. (2019) · Fluids and Barriers of the CNS · doi:10.1186/s12987-019-0136-7 · Cited by 117
Canfield, S. G., Stebbins, M. J., Faubion, M. G., Gastfriend, B. D., Palecek, S. P., & Shusta, E. V. (2019) · Fluids and Barriers of the CNS · doi:10.1186/s12987-019-0145-6 · Cited by 113
Self-citationGrifno, G. N., Farrell, A. M., Linville, R. M., Arevalo, D., Kim, J. H., Gu, L., & Searson, P. C. (2019) · Scientific Reports · doi:10.1038/s41598-019-50193-1 · Cited by 112
Commentary on human pluripotent stem cell-based blood–brain barrier models
Lippmann, E. S., Azarin, S. M., Palecek, S. P., & Shusta, E. V. (2020) · Fluids and Barriers of the CNS · doi:10.1186/s12987-020-00222-3 · Cited by 114
Self-citationFaley, S. L., Neal, E. H., Wang, J. X., Bosworth, A. M., Weber, C. M., Balotin, K. M., Lippmann, E. S., & Bellan, L. M. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.01.009 · Cited by 106
Katt, M. E., Linville, R. M., Mayo, L. N., Xu, Z. S., & Searson, P. C. (2018) · Fluids and Barriers of the CNS · doi:10.1186/s12987-018-0092-7 · Cited by 102
Nishihara, H., Gastfriend, B. D., Soldati, S., Perriot, S., Mathias, A., Sano, Y., Shimizu, F., Gosselet, F., Kanda, T., Palecek, S. P., et al. (2020) · The FASEB Journal · doi:10.1096/fj.202001507rr · Cited by 99
Self-citationOrgan-on-a-chip systems for vascular biology
Mandrycky, C., Howard, C. C., Rayner, S. G., Shin, Y. J., & Zheng, Y. Y. (2021) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2021.06.002 · Cited by 106
Organ‐On‐A‐Chip Models of the Blood–Brain Barrier: Recent Advances and Future Prospects
Kawakita, S., Mandal, K., Mou, L., Mecwan, M. M., Zhu, Y., Li, S., Sharma, S., Hernández, A. L., Nguyen, H. T., Maity, S., et al. (2022) · Small · doi:10.1002/smll.202201401 · Cited by 112
Williams, I. M., & Wu, J. C. (2019) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.119.312265 · Cited by 91
Oikari, L. E., Pandit, R., Stewart, R., Cuní-López, C., Quek, H., Sutharsan, R., Rantanen, L. M., Oksanen, M., Lehtonen, S., de Boer, C. M., et al. (2020) · Stem Cell Reports · doi:10.1016/j.stemcr.2020.03.011 · Cited by 90
Sex differences in the blood–brain barrier and neurodegenerative diseases
Weber, C. M., & Clyne, A. M. (2021) · APL Bioengineering · doi:10.1063/5.0035610 · Cited by 91
Blood–Brain Barrier and Neurodegenerative Diseases—Modeling with iPSC-Derived Brain Cells
Wu, Y.-C., Sonninen, T.-M., Peltonen, S., Koistinaho, J., & Lehtonen, Š. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147710 · Cited by 89
In vitro modeling of blood–brain barrier and interface functions in neuroimmune communication
Erickson, M. A., Wilson, M., & Banks, W. A. (2020) · Fluids and Barriers of the CNS · doi:10.1186/s12987-020-00187-3 · Cited by 104
A microengineered Brain-Chip to model neuroinflammation in humans
Pediaditakis, I., Kodella, K. R., Manatakis, D. V., Le, C. Y., Barthakur, S., Sorets, A., Gravanis, A., Ewart, L., Rubin, L. L., Manolakos, E. S., et al. (2022) · iScience · doi:10.1016/j.isci.2022.104813 · Cited by 88
Gastfriend, B. D., Nishihara, H., Canfield, S. G., Foreman, K. L., Engelhardt, B., Palecek, S. P., & Shusta, E. V. (2021) · eLife · doi:10.7554/elife.70992 · Cited by 96
Self-citationThe blood-brain barrier studied in vitro across species
Thomsen, M. S., Humle, N., Hede, E., Moos, T., Burkhart, A., & Thomsen, L. B. (2021) · PLOS ONE · doi:10.1371/journal.pone.0236770 · Cited by 79
Neural Lineage Differentiation From Pluripotent Stem Cells to Mimic Human Brain Tissues
Hong, Y. J., & Do, J. T. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00400 · Cited by 75
Sequential Targeting in Crosslinking Nanotheranostics for Tackling the Multibarriers of Brain Tumors
Wu, H., Lu, H., Xiao, W., Yang, J., Du, H., Shen, Y., Qu, H., Jia, B., Manna, S. K., Ramachandran, M., et al. (2020) · Advanced Materials · doi:10.1002/adma.201903759 · Cited by 83
Engineered tissues and strategies to overcome challenges in drug development
Khalil, A. S., Jaenisch, R., & Mooney, D. J. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.09.012 · Cited by 89
Models of the blood-brain barrier using iPSC-derived cells
Delsing, L., Herland, A., Falk, A., Hicks, R., Synnergren, J., & Zetterberg, H. (2020) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2020.103533 · Cited by 73
Pong, S., Karmacharya, R., Sofman, M., Bishop, J. R., & Lizano, P. L. (2020) · Complex Psychiatry · doi:10.1159/000511552 · Cited by 81
Maximizing the impact of microphysiological systems with in vitro–in vivo translation
Cirit, M., & Stokes, C. L. (2018) · Lab on a Chip · doi:10.1039/c8lc00039e · Cited by 70
Kurosawa, T., Tega, Y., Higuchi, K., Yamaguchi, T., Nakakura, T., Mochizuki, T., Kusuhara, H., Kawabata, K., & Deguchi, Y. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00697 · Cited by 69
An isogenic hiPSC-derived BBB-on-a-chip
Motallebnejad, P., Thomas, A., Swisher, S. L., & Azarin, S. M. (2019) · Biomicrofluidics · doi:10.1063/1.5123476 · Cited by 71
Dissecting the complexities of Alzheimer disease with in vitro models of the human brain
Blanchard, J., Victor, M. B., & Tsai, L. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-021-00578-6 · Cited by 74
Fu, X., Niu, T., & Li, X. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00866 · Cited by 66
Ohshima, M., Kamei, S., Fushimi, H., Mima, S., Yamada, T., & Yamamoto, T. (2019) · BioResearch open access · doi:10.1089/biores.2019.0026 · Cited by 69
Linville, R. M., Sklar, M. B., Grifno, G. N., Nerenberg, R. F., Zhou, J., Ye, R., DeStefano, J. G., Guo, Z., Jha, R., Jamieson, J. J., et al. (2022) · Fluids and Barriers of the CNS · doi:10.1186/s12987-022-00377-1 · Cited by 67
Praça, C., Rosa, S. C., Sevin, E., Cecchelli, R., Dehouck, M., & Ferreira, L. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.08.002 · Cited by 66
Micro/nanosystems for controllable drug delivery to the brain
Tian, M., Ma, Z., & Yang, G. (2023) · The Innovation · doi:10.1016/j.xinn.2023.100548 · Cited by 83
Salmina, A. B., Kharitonova, E. V., Gorina, Y. V., Тепляшина, Е. А., Malinovskaya, N. A., Хилажева, Е. Д., Mosiagina, A. I., Morgun, A. V., Shuvaev, А. N., Salmin, V. V., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094661 · Cited by 66
Yan, L., Moriarty, R. A., & Stroka, K. M. (2021) · Theranostics · doi:10.7150/thno.63195 · Cited by 62
Hemorrhagic Transformation After Tissue Plasminogen Activator Treatment in Acute Ischemic Stroke
Liu, C., Xie, J., Sun, S., Li, H., Li, T., Jiang, C. Q., Chen, X., Wang, J., Le, A., Wang, J., et al. (2020) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-00985-1 · Cited by 63
Youhanna, S. C., Kemas, A. M., Preiss, L. C., Zhou, Y., Shen, J. X., Cakal, S. D., Paqualini, F. S., Goparaju, S. K., Shafagh, R. Z., Lind, J. U., et al. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000238 · Cited by 67
Cellular complexity in brain organoids: Current progress and unsolved issues
Mansour, A. A., Schafer, S. T., & Gage, F. H. (2020) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2020.05.013 · Cited by 55
Human Induced Pluripotent Stem Cell-Derived Brain Endothelial Cells: Current Controversies
Lu, T. M., Durán, J. G. B., Houghton, S., Rafii, S., Redmond, D., & Lis, R. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.642812 · Cited by 58
Choi, J.-W., Seo, M., Kim, K., Kim, A.-R., Lee, H., Kim, H.-S., Park, C. G., Cho, S. W., Kang, J. H., Joo, J., et al. (2023) · ACS Nano · doi:10.1021/acsnano.2c11675 · Cited by 53
Vascularized human brain organoid on-chip
Tan, S. Y., Feng, X., Cheng, L. K., & Wu, A. R. (2023) · Lab on a Chip · doi:10.1039/d2lc01109c · Cited by 64
Appelt‐Menzel, A., Oerter, S., Mathew, S., Haferkamp, U., Hartmann, C., Jung, M., Neuhaus, W., & Pleß, O. (2020) · Current Protocols in Stem Cell Biology · doi:10.1002/cpsc.122 · Cited by 57
Kim, H. S., Seo, M., Park, T., & Lee, D. Y. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-01220-9 · Cited by 54
The Isolated Brain Microvessel: A Versatile Experimental Model of the Blood-Brain Barrier
Pardridge, W. M. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00398 · Cited by 50
Label-free imaging for quality control of cardiomyocyte differentiation
Qian, T., Heaster, T. M., Houghtaling, A. R., Sun, K., Samimi, K., & Skala, M. C. (2021) · Nature Communications · doi:10.1038/s41467-021-24868-1 · Cited by 58
Self-citationReview of Design Considerations for Brain-on-a-Chip Models
Cameron, T., Bennet, T. J., Rowe, E. M., Anwer, M., Wellington, C. L., & Cheung, K. C. (2021) · Micromachines · doi:10.3390/mi12040441 · Cited by 54
Sun, J., Ou, W., Han, D., Paganini-Hill, A., Fisher, M. J., & Sumbria, R. K. (2022) · PLOS ONE · doi:10.1371/journal.pone.0268860 · Cited by 47
“WISCi004-B) was differentiated into ihBMECs as described previously [31].”
BackgroundMethodEng, M. E., Império, G. E., Bloise, E., & Matthews, S. G. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04432-w · Cited by 53
Yamashita, M., Aoki, H., Hashita, T., Iwao, T., & Matsunaga, T. (2020) · Fluids and Barriers of the CNS · doi:10.1186/s12987-020-00197-1 · Cited by 47
Dynamic 3D On-Chip BBB Model Design, Development, and Applications in Neurological Diseases
Chen, X., Liu, C., Muok, L., Zeng, C., & Li, Y. (2021) · Cells · doi:10.3390/cells10113183 · Cited by 54
Estrogen Mediates an Atherosclerotic-Protective Action via Estrogen Receptor Alpha/SREBP-1 Signaling
Xie, F., Li, X., Xu, Y., Cheng, D., Xia, X., Lv, X., Yuan, G., & Peng, C. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.895916 · Cited by 53
Strategies for derivation of endothelial lineages from human stem cells
Xu, M., He, J., Zhang, C., Xu, J., & Wang, Y. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1274-1 · Cited by 48
Liu, Y., Wang, L., Du, N., Yin, X., Shao, H., & Lin, Y. (2021) · Inflammation · doi:10.1007/s10753-021-01451-w · Cited by 43
Wellens, S., Dehouck, L., Chandrasekaran, V., Singh, P., Loiola, R. A., Sevin, E., Exner, T. E., Jennings, P., Gosselet, F., & Culot, M. (2021) · Toxicology in Vitro · doi:10.1016/j.tiv.2021.105112 · Cited by 46
Advanced Human BBB‐on‐a‐Chip: A New Platform for Alzheimer's Disease Studies
Yoon, J., Kim, J., Shah, Z., Awasthi, A., Mahajan, A., & Kim, Y. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202002285 · Cited by 49
Harnessing cerebral organoids for Alzheimer's disease research
Bubnys, A., & Tsai, L. (2021) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2021.10.003 · Cited by 44
Multiple sclerosis: Immunopathological heterogeneity and its implications
Engelhardt, B., Comabella, M., & Chan, A. (2022) · European Journal of Immunology · doi:10.1002/eji.202149757 · Cited by 47
Choublier, N., Taghi, M., Menet, M., Gall, M. L., Bruce, J., Chafey, P., Guillonneau, F., Moreau, A., Denizot, C., Parmentier, Y., et al. (2022) · Fluids and Barriers of the CNS · doi:10.1186/s12987-022-00344-w · Cited by 45
Huang, J., Li, Y. B., Charlebois, C., Nguyen, T., Liu, Z., Bloemberg, D., Zafer, A., Baumann, E., Sodja, C., Leclerc, S., et al. (2022) · Fluids and Barriers of the CNS · doi:10.1186/s12987-022-00342-y · Cited by 43
Synergistic induction of blood–brain barrier properties
Porkoláb, G., Mészáros, M., Szecskó, A., Vigh, J. P., Walter, F. R., de Figueiredo, R. M., Kálomista, I., Hoyk, Z., Vizsnyiczai, G., Gróf, I., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2316006121 · Cited by 40
Directed Differentiation of Human Pluripotent Stem Cells to Podocytes under Defined Conditions
Qian, T., Hernday, S. E., Bao, X., Olson, W. R., Panzer, S. E., Shusta, E. V., & Palecek, S. P. (2019) · Scientific Reports · doi:10.1038/s41598-019-39504-8 · Cited by 39
Self-citationStreptococcus agalactiae disrupts P-glycoprotein function in brain endothelial cells
Kim, B. J., McDonagh, M. A., Deng, L., Gastfriend, B. D., Schubert‐Unkmeir, A., Doran, K. S., & Shusta, E. V. (2019) · Fluids and Barriers of the CNS · doi:10.1186/s12987-019-0146-5 · Cited by 38
Self-citationIn Vitro Blood–Brain Barrier-Integrated Neurological Disorder Models Using a Microfluidic Device
Choi, J., Santhosh, M., & Choi, J.-W. (2019) · Micromachines · doi:10.3390/mi11010021 · Cited by 37
Luo, J., Shi, X., Lin, Y., Yuan, Y., Kural, M. H., Wang, J., Ellis, M. W., Anderson, C. W., Zhang, S., Riaz, M., et al. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.11.007 · Cited by 37
Engdahl, E., van Schijndel, M. D. M., Voulgaris, D., Criscio, M. D., Ramsbottom, K. A., Rigden, D. J., Herland, A., & Rüegg, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115534 · Cited by 37
Gama, C. S. D., & Morin‐Brureau, M. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.863836 · Cited by 38
Chen, X., Liu, C., McDaniel, G., Zeng, O. Z., Ali, J., Zhou, Y., Wang, X. S., Driscoll, T. P., Zeng, C., & Li, Y. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202402199 · Cited by 40
Motallebnejad, P., & Azarin, S. M. (2020) · Fluids and Barriers of the CNS · doi:10.1186/s12987-020-00215-2 · Cited by 32
Lubricant‐Coated Organ‐on‐a‐Chip for Enhanced Precision in Preclinical Drug Testing
Kim, T. Y., Choi, J., Park, K., Kim, S., Kim, J. F., Park, T., & Seo, J. (2024) · Small · doi:10.1002/smll.202402431 · Cited by 35
Three-dimensional induced pluripotent stem-cell models of human brain angiogenesis
Linville, R. M., Arevalo, D., Maressa, J. C., Zhao, N., & Searson, P. C. (2020) · Microvascular Research · doi:10.1016/j.mvr.2020.104042 · Cited by 34
Cao, H., Zhou, Q., Liu, C., Zhang, Y., Xie, M., Qiao, W., & Dong, N. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.02.032 · Cited by 36
Albekairi, T. H., Vaidya, B., Patel, R., Nozohouri, S., Villalba, H., Zhang, Y., Lee, Y. S., Al-Ahmad, A. J., & Abbruscato, T. J. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11090467 · Cited by 33
Cai, Y., Fan, K., Lin, J., Ma, L., & Li, F. (2022) · Micromachines · doi:10.3390/mi14010112 · Cited by 29
A guide for blood–brain barrier models
Soliman, Y., Al‐khodor, J., Koken, G. Y., & Mustafaoğlu, N. (2024) · FEBS Letters · doi:10.1002/1873-3468.15053 · Cited by 32
Generation of a Human iPSC-Based Blood-Brain Barrier Chip
Jagadeesan, S., Workman, M. J., Herland, A., Svendsen, C. N., & Vatine, G. D. (2020) · Journal of Visualized Experiments · doi:10.3791/60925 · Cited by 30
Traumatic brain injury: Bridging pathophysiological insights and precision treatment strategies
Lu, Y., Jin, J., Zhang, H., Lu, Q., Zhang, Y., Liu, C., Liang, Y., Tian, S., Zhao, Y., & Fan, H. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-01398 · Cited by 32
Brain Barriers and Multiple Sclerosis: Novel Treatment Approaches from a Brain Barriers Perspective.
Nishihara, H., & Engelhardt, B. (2020) · Handbook of Experimental Pharmacology · doi:10.1007/164_2020_407 · Cited by 15
Engineering the Human Blood–Brain Barrier at the Capillary Scale using a Double‐Templating Technique
Zhao, N., Guo, Z., Kulkarni, S., Norman, D., Zhang, S., Chung, T. D., Nerenberg, R. F., Linville, R. M., & Searson, P. C. (2022) · Advanced Functional Materials · doi:10.1002/adfm.202110289 · Cited by 31
Past and Current Perspectives in Modeling Bacteria and Blood–Brain Barrier Interactions
Kim, B. J., Shusta, E. V., & Doran, K. S. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01336 · Cited by 29
Self-citationGensheimer, T., Veerman, D., van Oosten, E., Segerink, L. I., Garanto, A., & van der Meer, A. D. (2025) · Lab on a Chip · doi:10.1039/d4lc00823e · Cited by 30
Advancing brain barriers RNA sequencing: guidelines from experimental design to publication
Francisco, D. M. F., Marchetti, L., Rodríguez‐Lorenzo, S., Frías-Anaya, E., de Figueiredo, R. M., BtRAIN Network, Heymans, M., Culot, M., Santa-Maria, A. R., Deli, M. A., et al. (2020) · Fluids and Barriers of the CNS · doi:10.1186/s12987-020-00207-2 · Cited by 31
Casas, B. S., Vitória, G., Prieto, C. P., Casas, M., Chacón, C., Uhrig, M., Ezquer, F. E., Ezquer, M., Rehen, S. K., & Palma, V. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01653-0 · Cited by 29
Li, Y., Xia, Y., Zhu, H., Luu, E., Huang, G., Sun, Y., Sun, K., Markx, S., Leong, K. W., Xu, B., et al. (2021) · Cells · doi:10.3390/cells10102576 · Cited by 27
Modelling the Human Blood–Brain Barrier in Huntington Disease
Vignone, D., Paz, O. G., Fini, I., Cellucci, A., Auciello, G., Battista, M. R., Gloaguen, I., Fortuni, S., Cariulo, C., Khetarpal, V. K., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147813 · Cited by 25
Lall, D., Workman, M. J., Sances, S., Ondatje, B. N., Bell, S., Lawless, G. M., Woodbury, A., West, D., Meyer, A. S., Matlock, A. D., et al. (2025) · Cell stem cell · doi:10.1016/j.stem.2025.05.015 · Cited by 32
Metadata
- Authors
- Qian, T., Maguire, S. E., Canfield, S. G., Bao, X., Olson, W. R., Shusta, E. V., & Palecek, S. P.
- Affiliations
- University of Wisconsin–Madison (US)
- Corresponding author
- Shusta, Eric V.
- Palecek, Sean P.
- ORCID
- Venue
- Science Advances
- Published
- 2017-11-03
- Volume
- 3
- Issue
- 11
- Pages
- e1701679-e1701679
- ISSN
- 2375-2548 (ISSN-L)
- PMC
- PMC5677350
- OpenAlex
- W2767330810
- Cited by
- 254
- References
- 79
- Citations by year
- 2026: 20 · 2025: 21 · 2024: 34 · 2023: 24 · 2022: 48 · 2021: 36 · 2020: 31 · 2019: 28 · 2018: 12
- FWCI
- 9.67
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Science Advances (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (award324272, R21 NS085351, award324273, R01 NS083699)
- National Institute of Biomedical Imaging and Bioengineering (award324271, R01 EB007534)
- Takeda Pharmaceuticals U.S.A. (award324274)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Keywords
- human pluripotent stem cells, blood-brain barrier endothelial cells, directed differentiation, in vitro BBB model, brain disorders, treatment development
- MeSH terms
- Blood-Brain Barrier, Cell Differentiation, Humans, Phenotype, Transcription Factors, Electric Impedance, Coculture Techniques, Cell Lineage, Pluripotent Stem Cells, Endothelial Cells, Transcriptome, Claudin-5
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.